165 related articles for article (PubMed ID: 22859903)
21. Degradation products of different water content sevoflurane in carbon dioxide absorbents by gas chromatography-mass spectrometry analysis.
Li Y; Li YC; Zhang YN; Liu SJ; Zhou YM; Wang CS; Gong YL; Li EY
Chin Med J (Engl); 2011 Apr; 124(7):1050-4. PubMed ID: 21542967
[TBL] [Abstract][Full Text] [Related]
22. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans.
Mchaourab A; Arain SR; Ebert TJ
Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591
[TBL] [Abstract][Full Text] [Related]
23. Dry soda lime markedly degrades sevoflurane during simulated inhalation induction.
Funk W; Gruber M; Wild K; Hobbhahn J
Br J Anaesth; 1999 Feb; 82(2):193-8. PubMed ID: 10364992
[TBL] [Abstract][Full Text] [Related]
24. Single vital-capacity and successive tidal-volume breathing of sevoflurane in induction of anesthesia for tracheal intubation in gynecologic patients.
Lin TC; Lu CC; Kuo CK; Hsu CH; Huang GS; Liu JY; Ho ST
Acta Anaesthesiol Taiwan; 2008 Jun; 46(2):66-70. PubMed ID: 18593651
[TBL] [Abstract][Full Text] [Related]
25. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
Eger EI; Gong D; Koblin DD; Bowland T; Ionescu P; Laster MJ; Weiskopf RB
Anesth Analg; 1997 Nov; 85(5):1154-63. PubMed ID: 9356118
[TBL] [Abstract][Full Text] [Related]
26. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers.
Goldberg ME; Cantillo J; Gratz I; Deal E; Vekeman D; McDougall R; Afshar M; Zafeiridis A; Larijani G
Anesth Analg; 1999 Feb; 88(2):437-45. PubMed ID: 9972771
[TBL] [Abstract][Full Text] [Related]
27. Sevoflurane degradation to compound A in anaesthesia breathing systems.
Cunningham DD; Huang S; Webster J; Mayoral J; Grabenkort RW
Br J Anaesth; 1996 Oct; 77(4):537-43. PubMed ID: 8942344
[TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of three methods of induction of anaesthesia with sevoflurane.
Knaggs CL; Drummond GB
Br J Anaesth; 2005 Aug; 95(2):178-82. PubMed ID: 15863438
[TBL] [Abstract][Full Text] [Related]
29. Production of compound A under low-flow anesthesia is affected by type of anesthetic machine.
Yamakage M; Kimura A; Chen X; Tsujiguchi N; Kamada Y; Namiki A
Can J Anaesth; 2001 May; 48(5):435-8. PubMed ID: 11394509
[TBL] [Abstract][Full Text] [Related]
30. Production of compound A and carbon monoxide in circle systems: an in vitro comparison of two carbon dioxide absorbents.
Struys MM; Bouche MP; Rolly G; Vandevivere YD; Dyzers D; Goeteyn W; Versichelen LF; Van Bocxlaer JF; Mortier EP
Anaesthesia; 2004 Jun; 59(6):584-9. PubMed ID: 15144299
[TBL] [Abstract][Full Text] [Related]
31. Compound A concentration in the circle absorber system during low-flow sevoflurane anesthesia: comparison of Drägersorb Free, Amsorb, and Sodasorb II.
Kobayashi S; Bito H; Obata Y; Katoh T; Sato S
J Clin Anesth; 2003 Feb; 15(1):33-7. PubMed ID: 12657409
[TBL] [Abstract][Full Text] [Related]
32. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia.
Bito H; Ikeuchi Y; Ikeda K
Anesthesiology; 1997 Jun; 86(6):1231-7. PubMed ID: 9197291
[TBL] [Abstract][Full Text] [Related]
33. Comparison of single-breath vital capacity rapid inhalation with sevoflurane 5% and propofol induction on QT interval and haemodynamics for laparoscopic surgery.
Sen S; Ozmert G; Boran N; Turan H; Caliskan E
Eur J Anaesthesiol; 2004 Jul; 21(7):543-6. PubMed ID: 15318466
[TBL] [Abstract][Full Text] [Related]
34. Carbon dioxide absorbents containing potassium hydroxide produce much larger concentrations of compound A from sevoflurane in clinical practice.
Yamakage M; Yamada S; Chen X; Iwasaki S; Tsujiguchi N; Namiki A
Anesth Analg; 2000 Jul; 91(1):220-4. PubMed ID: 10866916
[TBL] [Abstract][Full Text] [Related]
35. The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers.
Eger EI; Gong D; Koblin DD; Bowland T; Ionescu P; Laster MJ; Weiskopf RB
Anesth Analg; 1998 Feb; 86(2):414-21. PubMed ID: 9459259
[TBL] [Abstract][Full Text] [Related]
36. Effect of smoking on induction of anaesthesia with sevoflurane.
Mendonca C; Thorpe C
Anaesthesia; 2001 Jan; 56(1):19-23. PubMed ID: 11167431
[TBL] [Abstract][Full Text] [Related]
37. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers.
Ebert TJ; Messana LD; Uhrich TD; Staacke TS
Anesth Analg; 1998 Mar; 86(3):662-7. PubMed ID: 9495434
[TBL] [Abstract][Full Text] [Related]
38. Sevoflurane versus isoflurane: induction and recovery characteristics with single-breath inhaled inductions of anesthesia.
Sloan MH; Conard PF; Karsunky PK; Gross JB
Anesth Analg; 1996 Mar; 82(3):528-32. PubMed ID: 8623956
[TBL] [Abstract][Full Text] [Related]
39. Conventional stepwise vs. vital capacity rapid inhalation induction at two concentrations of sevoflurane.
MartÃn-Larrauri R; Gilsanz F; Rodrigo J; Vila P; Ledesma M; Casimiro C
Eur J Anaesthesiol; 2004 Apr; 21(4):265-71. PubMed ID: 15109188
[TBL] [Abstract][Full Text] [Related]
40. Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric ambulatory patients.
Welborn LG; Hannallah RS; Norden JM; Ruttimann UE; Callan CM
Anesth Analg; 1996 Nov; 83(5):917-20. PubMed ID: 8895263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]